Blood Test Shows Promise for Detecting Cancers Without Approved Screening Tests
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
A novel blood test can detect cancers that currently have no standard screening procedures, a study suggests.
Transgender patients with cancer may be less likely to receive adequate care and have worse outcomes than their cisgender counterparts.
The prevalence of metastatic cancers in the US has risen in recent years and will increase further by 2025, according to researchers.
Investigators sought to determine the efficacy and safety of N-803 plus BCG in patients with high-risk NMIBC.
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
A new cancer diagnosis is independently associated with a higher risk of cardiovascular death, stroke, heart failure, and pulmonary embolism.
Men of African ancestry had the highest risk of developing metastatic prostate cancer when compared with men of other ancestries.
The excess risk of cancer appeared to be associated with the severity of heart failure.
An update to active surveillance recommendations has some physicians concerned.
Certain treatments were associated with an increased risk of death unrelated to testicular cancer.